icad Inc (ICAD)

4.73
0.23 4.60
NASDAQ : Technology
Prev Close 4.96
Open 4.90
Day Low/High 4.70 / 4.91
52 Wk Low/High 2.95 / 6.23
Volume 33.60K
Avg Volume 41.20K
Exchange NASDAQ
Shares Outstanding 16.16M
Market Cap 81.11M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ICAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment At AAD 2017

ICAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment At AAD 2017

Company to highlight breakthrough Xoft System offering excellent clinical results and host in-booth Lunch and Learn sessions featuring clinical experts to discuss strategies and outcomes in patient care

First-Ever Analysis Of Intraoperative Radiation Therapy With Xoft System As A Boost Prior To Whole Breast Radiation To Be Presented At San Antonio Breast Cancer Symposium

First-Ever Analysis Of Intraoperative Radiation Therapy With Xoft System As A Boost Prior To Whole Breast Radiation To Be Presented At San Antonio Breast Cancer Symposium

Results show low morbidity, excellent-to-good cosmetic results, and low-grade adverse events for patients with early-stage breast cancer

ICAD To Showcase Use Of Artificial Intelligence In Medical Imaging At RSNA 2016

ICAD To Showcase Use Of Artificial Intelligence In Medical Imaging At RSNA 2016

Company highlighting latest in deep learning technology used to detect cancer earlier and improve workflow

ICAD Announces Management Transition

ICAD Announces Management Transition

First Cervical Cancer Patient Treated In Europe With The Xoft System At Hospital Universitario Miguel Servet In Spain

First Cervical Cancer Patient Treated In Europe With The Xoft System At Hospital Universitario Miguel Servet In Spain

Multi-platform Xoft electronic brachytherapy system brings versatility and mobility to clinicians

ICAD Commends Final USPSTF Recommendations For Colorectal Cancer Screening Including Computed Tomography Colonography (CTC)

ICAD Commends Final USPSTF Recommendations For Colorectal Cancer Screening Including Computed Tomography Colonography (CTC)

Grade "A" assigned to colorectal cancer screening exams by United States Preventive Services Task Force

ICAD Announces Increased Adoption Of IRevealĀ® Automated Breast Density Solution In U.S.

ICAD Announces Increased Adoption Of IRevealĀ® Automated Breast Density Solution In U.S.

Momentum reflects response to state mandated breast density notifications and healthcare provider confidence in iCAD's radiology workflow solution platform

ICAD Announces Computer Aided Detection Solution For Fujifilm's Aspire Cristalle Full Field Digital Mammography

ICAD Announces Computer Aided Detection Solution For Fujifilm's Aspire Cristalle Full Field Digital Mammography

iCAD, Inc., (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, today announced that its mammography Computer...

ICAD Showcases Latest Technology Supporting Use Of Xoft System For Non-melanoma Skin Cancer Treatment At AAD 2016

ICAD Showcases Latest Technology Supporting Use Of Xoft System For Non-melanoma Skin Cancer Treatment At AAD 2016

Company highlights new SMART solution designed to enhance workflow efficiency, flexibility, safety and security of the Xoft System

ICAD Announces Breakthrough Technology For Use With Digital Breast Tomosynthesis Exams At The European Congress Of Radiology

ICAD Announces Breakthrough Technology For Use With Digital Breast Tomosynthesis Exams At The European Congress Of Radiology

Workflow tools offer significant productivity and efficiency

ICad Completes Acquisition Of VuCOMP's Cancer Detection Portfolio

ICad Completes Acquisition Of VuCOMP's Cancer Detection Portfolio

Acquisition expands iCAD's presence as the largest independent provider of mammography computer aided detection and workflow solutions and augments deep learning capabilities

ICAD Expands Use Of The Xoft Electronic Brachytherapy System In Europe, Asia And Australia

ICAD Expands Use Of The Xoft Electronic Brachytherapy System In Europe, Asia And Australia

Increased Global Demand for Leading-Edge Cancer Treatment Drives Adoption of Eight Xoft Systems for Intraoperative Radiation Therapy (IORT), Offering Significant Benefits to Patients and Clinicians